CBLL Key Statistics, Chart & Performance
The current stock price of CBLL is 23.33 USD. In the past month the price increased by 15.61%. In the past year, price increased by 11.47%.
CBLL Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.23 | 218.96B | ||
| ISRG | INTUITIVE SURGICAL INC | 68.09 | 207.82B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.1 | 144.75B | ||
| SYK | STRYKER CORP | 27.91 | 140.55B | ||
| BDX | BECTON DICKINSON AND CO | 14.06 | 57.87B | ||
| IDXX | IDEXX LABORATORIES INC | 56.57 | 56.96B | ||
| EW | EDWARDS LIFESCIENCES CORP | 33.12 | 49.40B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 19.02 | 39.76B | ||
| RMD | RESMED INC | 25.5 | 36.85B | ||
| DXCM | DEXCOM INC | 36.24 | 26.29B | ||
| PODD | INSULET CORP | 63.25 | 20.33B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.48 | 18.40B |
Related stock screener links
About CBLL
Company Profile
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The firm has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
Company Info
CERIBELL INC
360 N. Pastoria Avenue
Sunnyvale CALIFORNIA US
Employees: 281
Phone: 18004360826
CERIBELL INC / CBLL FAQ
Can you describe the business of CERIBELL INC?
Ceribell, Inc. is a commercial-stage medical technology company, which engages in the provision of transforming the diagnosis and management of patients with serious neurological conditions. The company is headquartered in Sunnyvale, California and currently employs 281 full-time employees. The company went IPO on 2024-10-11. The firm has developed the Ceribell System, a point-of-care electroencephalography (EEG) platform specifically designed to address the unmet needs of patients in the acute care setting. By combining highly portable and rapidly deployable hardware with artificial intelligence-powered algorithms, the Ceribell System enables rapid diagnosis and continuous monitoring of patients with neurological conditions. The Ceribell System is FDA-cleared (510(k)) for indicating suspected seizure activity and utilized in intensive care units and emergency rooms across the United States. Clarity, its machine learning algorithm, continuously interprets a patient’s EEG waveforms and displays actionable insights regarding seizure activity on the recorder. Its EEG portal is a cloud-based portal that enables real-time remote access to a patient’s EEG data.
What is the stock price of CERIBELL INC today?
The current stock price of CBLL is 23.33 USD. The price increased by 1.13% in the last trading session.
What is the dividend status of CERIBELL INC?
CBLL does not pay a dividend.
What is the ChartMill rating of CERIBELL INC stock?
CBLL has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
What is the analyst forecast for CBLL stock?
14 analysts have analysed CBLL and the average price target is 28.56 USD. This implies a price increase of 22.42% is expected in the next year compared to the current price of 23.33.
What is the Price/Earnings (PE) ratio of CERIBELL INC (CBLL)?
CERIBELL INC (CBLL) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.51).
Can you provide the short interest for CBLL stock?
The outstanding short interest for CERIBELL INC (CBLL) is 5.49% of its float.
CBLL Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to CBLL. When comparing the yearly performance of all stocks, CBLL is one of the better performing stocks in the market, outperforming 92.98% of all stocks.
CBLL Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CBLL. The financial health of CBLL is average, but there are quite some concerns on its profitability.
CBLL Financial Highlights
Over the last trailing twelve months CBLL reported a non-GAAP Earnings per Share(EPS) of -1.51. The EPS decreased by -30.29% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -26.29% | ||
| ROE | -31.97% | ||
| Debt/Equity | 0.12 |
CBLL Forecast & Estimates
14 analysts have analysed CBLL and the average price target is 28.56 USD. This implies a price increase of 22.42% is expected in the next year compared to the current price of 23.33.
For the next year, analysts expect an EPS growth of 31.49% and a revenue growth 37.29% for CBLL